Hemochromic cardiomyopathy

Hemachromatosis (HCH) is a chronic systemic disorder of iron metabolism, which has a worldwide distribution. In 1865, Troussean reported that there are more and more reports about the disease in the world. The disease is characterized by a hereditary iron metabolism disorder, with hemosiderin deposited in tissues, causing damage to the liver, spleen, adrenal glands, pituitary, pancreas, heart and other organs, fibrous hyperplasia, structural destruction and dysfunction.

The material in this site is intended to be of general informational use and is not intended to constitute medical advice, probable diagnosis, or recommended treatments.